Clinical Trial Update: Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A phase 1 vaccine therapy trial for patients with stage IB-IIIA non-small cell lung cancer undergoing surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: TERMINATED